Aktienanalyse zu Precision Optics Corporation Inc (POCI)POCIPrecision Optics Corporation Inc

Precision Optics Corporation, Inc. is a developer and manufacturer of optical instruments. The Company’s segments include medical devices and advanced defense/aerospace products. Its optical and imaging technology, custom designs, manufacturing capabilities, and engineering and development capabilities have generated traditional endoscopes and endocouplers, digital imaging endoscopes using complementary metal-oxide-semiconductor (CMOS) sensor technology, some designed and manufactured for single-use, as well as other custom imaging and illumination products for our customers’ use in minimally invasive surgical procedures. It designs and manufactures precision endoscopes and microprecision lenses, assemblies and complete medical devices to meet the surgical community’s demand for imaging systems for minimally invasive surgery. Its technologies serve defense / aerospace markets, including applications supporting satellite network communications. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Precision Optics Corporation Inc is a good buy right now due to its recent strong revenue growth, with Q3 revenue increasing by 107.1% year-over-year to $8.7 million, and a current price of $4.80, which is significantly below its 52-week high of $6.15. The RSI is at 80.676, indicating strong momentum, although it is approaching overbought levels. The main risk is the negative net income, which was -$103,787 in Q4 2026, but the trend is improving as the company moves towards profitability.